The
global Medical
Foods Market size is anticipated to reach USD 33.4 billion by
2030, growing at a CAGR of 5.1% during the forecast period, according to a new
report by Grand View Research, Inc. Rising geriatric population, prevalence of
chronic diseases, a shift toward consuming disease-specific formulas, and a
growing demand for neonatal and preterm enteral feeding are some of the factors
driving this growth.
The
oral route of the administration segment dominated the market in 2023. The
major factors contributing to this growth include a high preference for oral
medical foods owing to the ease of consumption and high commercial viability of
products administered orally. In addition, these foods are available in a
variety of forms such as pills, powder, puddings, and pre-thickened products,
thereby fueling the segment’s growth.
In
2023, the powder product segment accounted for the largest revenue share.
Factors contributing to the growth include the rising application areas of
powdered medical foods, ease of administration, and higher commercial
viability. The liquid segment is anticipated to grow at the fastest CAGR from
2024 to 2030, owing to the ease of consumption of liquid-based foods for
special medical purposes by the pediatric and geriatric population.
The
chemotherapy-induced diarrhea emerged as the largest application segment in
2023. Diarrhea caused by chemotherapy treatment is one of the common problems
among cancer patients and the rising prevalence of cancer is one of the major
reasons for this increasing the revenue share. For instance, according to the
National Cancer Institute statistics, about half of the patients develop
diarrhea when treated with chemotherapy agents and the rate can reach 80% with
respect to certain chemotherapy agents.
The
institutional sales channel segment dominated the market in 2023. Higher
penetration and adoption of oral and enteral medical foods in the healthcare
institutions such as clinics, hospitals, and care centers and the rising
consumption of these products are some of the major factors contributing to the
large revenue share. In addition, the rising demand for such products in
inpatient facilities and increasing adoption for such products are boosting the
market growth.
North
America dominated the market with a revenue share of approximately 30% in
2023.. The presence of major players and high revenue generated by them in the
region are the key factors contributing to this growth. In addition, strategic
developments, the growing prevalence of chronic conditions, and the increasing
adoption of medical foods by patients and healthcare professionals are the
other factors supporting the growth.
Related Press
Release@ Medical
Foods Market Report
Medical Foods Market Report Highlights
- The oral
route of the administration segment dominated the market in 2023
- The powder
product segment accounted for the largest revenue share in 2023
- Chemotherapy-induced
diarrhea emerged as the leading application segment in 2023
- The institutional
sales channel segment held the largest revenue share in 2023
- In 2023,
North America held the largest revenue share, due to the increasing
prevalence of chronic diseases and the presence of key players
- Key players
in the medical foods industry are driving growth through strategies like
collaborations, acquisitions, and product launches. For instance, in May
2022, Nestlé Health Science acquired a premium Brazilian health and
nutrition lifestyle brand, Puravida. This acquisition aims to expand Nestlé's
customer base in Brazil.
Medical Foods Market Segmentation
Grand
View Research has segmented the global medical foods market based on route of
administration, product, application, sales channel, and region:
Medical Foods Route of Administration Outlook
(Revenue, USD Million, 2018 - 2030)
- Oral
- Enteral
Medical Foods Product Outlook (Revenue, USD Million,
2018 - 2030)
- Powder
- Pills
- Liquid
- Other
Medical Foods Application Outlook (Revenue, USD
Million, 2018 - 2030)
- Chronic
Kidney Disease
- Minimal
Hepatic Encephalopathy
- Chemotherapy-induced
Diarrhea
- Pathogen
Related Infections
- Diabetic
Neuropathy
- ADHD
- Depression
- Alzheimer's
Disease
- Nutritional
Deficiency
- Orphan
Diseases
- Phenylketonuria
- Eosinophilic
Esophagitis
- FPIES
- MSUD
- Homocystinuria
- Tyrosinemia
- Others
- Wound
Healing
- Chronic
Diarrhea
- Constipation
Relief
- Protein
Booster
- Dysphagia
- Pain
Management
- Parkinson's
Disease
- Epilepsy
- Other Cancer
Related Treatments
- Severe
Protein Allergy
- Cachexia
- Other
Medical Foods Sales Channel Outlook (Revenue, USD
Million, 2018 - 2030)
- Online Sales
- Retail Sales
- Institutional
Sales
Medical Foods Regional Outlook (Revenue, USD
Million, 2018 - 2030)
- North
America
- U.S
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Latin
America
- Brazil
- Mexico
- Argentina
- Middle East
and Africa (MEA)
- Saudi
Arabia
- UAE
- South
Africa
- Kuwait
- Qatar
